Skip to main content
Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
19.30
+0.27 (1.42%)
At close: Sep 26, 2025, 4:00 PM EDT
19.09
-0.21 (-1.09%)
After-hours: Sep 26, 2025, 7:38 PM EDT

Schrödinger Revenue by Type
Period Ending Jun 30, 2025Jun 30, 2025Jun 30, 2025Mar 31, 2025Mar 31, 2025Mar 31, 2025Dec 31, 2024Dec 31, 2024Dec 31, 2024Sep 30, 2024Sep 30, 2024Sep 30, 2024Jun 30, 2024Jun 30, 2024Jun 30, 2024Mar 31, 2024Mar 31, 2024Mar 31, 2024Dec 31, 2023Dec 31, 2023Dec 31, 2023Sep 30, 2023Sep 30, 2023Sep 30, 2023Jun 30, 2023Jun 30, 2023Jun 30, 2023Mar 31, 2023Mar 31, 2023Mar 31, 2023Dec 31, 2022Dec 31, 2022Dec 31, 2022
Software Products and Services
200.94M 200.94M 200.94M 195.80M 195.80M 195.80M 180.40M 180.40M 180.40M 169.40M 169.40M 169.40M 166.42M 166.42M 166.42M 160.37M 160.37M 160.37M 159.17M 159.17M 159.17M 138.27M 138.27M 138.27M
Software Products and Services Growth
20.74% 20.74% 20.74% 22.09% 22.09% 22.09% 13.34% 13.34% 13.34% 22.52% 22.52% 22.52% 24.17% 24.17% 24.17% 19.07% 19.07% 19.07% 17.42% 17.42% 17.42% - - -
Drug Discovery
37.06M 37.06M 37.06M 34.77M 34.77M 34.77M 27.22M 27.22M 27.22M 24.02M 24.02M 24.02M 34.28M 34.28M 34.28M 28.19M 28.19M 28.19M 57.57M 57.57M 57.57M 61.07M 61.07M 61.07M
Drug Discovery Growth
8.10% 8.10% 8.10% 23.37% 23.37% 23.37% -52.72% -52.72% -52.72% -60.67% -60.67% -60.67% -42.60% -42.60% -42.60% -54.79% -54.79% -54.79% 26.94% 26.94% 26.94% - - -

Software Products and Services Revenue Breakdown
Period Ending Jun 30, 2025Jun 30, 2025Jun 30, 2025Mar 31, 2025Mar 31, 2025Mar 31, 2025Dec 31, 2024Dec 31, 2024Dec 31, 2024Sep 30, 2024Sep 30, 2024Sep 30, 2024Jun 30, 2024Jun 30, 2024Jun 30, 2024Mar 31, 2024Mar 31, 2024Mar 31, 2024Dec 31, 2023Dec 31, 2023Dec 31, 2023Sep 30, 2023Sep 30, 2023Sep 30, 2023Jun 30, 2023Jun 30, 2023Jun 30, 2023Mar 31, 2023Mar 31, 2023Mar 31, 2023Dec 31, 2022Dec 31, 2022Dec 31, 2022Sep 30, 2022Sep 30, 2022Sep 30, 2022Jun 30, 2022Jun 30, 2022Jun 30, 2022
Software Products and Services
27.13M 27.13M 27.13M 26.27M 26.27M 26.27M 23.32M 23.32M 23.32M
Software Products and Services Growth
6.96% 6.96% 6.96% 13.80% 13.80% 13.80% 1.39% 1.39% 1.39%
Software Contribution
16.37M 16.37M 16.37M 13.66M 13.66M 13.66M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Drug Discovery
9.03M 9.03M 9.03M 7.96M 7.96M 7.96M 8.98M 8.98M 8.98M
Drug Discovery Growth
7.57% 7.57% 7.57% -8.59% -8.59% -8.59% -5.58% -5.58% -5.58%

Drug Discovery Revenue Breakdown
Period Ending Jun 30, 2025Jun 30, 2025Jun 30, 2025Mar 31, 2025Mar 31, 2025Mar 31, 2025Dec 31, 2024Dec 31, 2024Dec 31, 2024Sep 30, 2024Sep 30, 2024Sep 30, 2024Jun 30, 2024Jun 30, 2024Jun 30, 2024Mar 31, 2024Mar 31, 2024Mar 31, 2024Dec 31, 2023Dec 31, 2023Dec 31, 2023Sep 30, 2023Sep 30, 2023Sep 30, 2023Jun 30, 2023Jun 30, 2023Jun 30, 2023Mar 31, 2023Mar 31, 2023Mar 31, 2023Dec 31, 2022Dec 31, 2022Dec 31, 2022
Drug Discovery Services Customer Contracts
35.12M 35.12M 35.12M 32.69M 32.69M 32.69M 25.14M 25.14M 25.14M 21.97M 21.97M 21.97M 31.88M 31.88M 31.88M 25.61M 25.61M 25.61M 54.72M 54.72M 54.72M 58.22M 58.22M 58.22M
Drug Discovery Services Customer Contracts Growth
10.16% 10.16% 10.16% 27.64% 27.64% 27.64% -54.05% -54.05% -54.05% -62.27% -62.27% -62.27% -44.26% -44.26% -44.26% -57.31% -57.31% -57.31% 26.00% 26.00% 26.00% - - -
Drug Discovery Contribution
1.89M 1.89M 1.89M 2.04M 2.04M 2.04M 2.03M 2.03M 2.03M 2.02M 2.02M 2.02M 2.37M 2.37M 2.37M 2.55M 2.55M 2.55M 2.82M 2.82M 2.82M 2.88M 2.88M 2.88M
Drug Discovery Contribution Growth
-20.12% -20.12% -20.12% -19.95% -19.95% -19.95% -28.03% -28.03% -28.03% -29.72% -29.72% -29.72% -6.89% -6.89% -6.89% 7.24% 7.24% 7.24% 44.72% 44.72% 44.72% - - -

Revenue by Geography
Period Ending Jun 30, 2025Jun 30, 2025Jun 30, 2025Mar 31, 2025Mar 31, 2025Mar 31, 2025Dec 31, 2024Dec 31, 2024Dec 31, 2024Sep 30, 2024Sep 30, 2024Sep 30, 2024Jun 30, 2024Jun 30, 2024Jun 30, 2024Mar 31, 2024Mar 31, 2024Mar 31, 2024Dec 31, 2023Dec 31, 2023Dec 31, 2023Sep 30, 2023Sep 30, 2023Sep 30, 2023Jun 30, 2023Jun 30, 2023Jun 30, 2023Mar 31, 2023Mar 31, 2023Mar 31, 2023Dec 31, 2022Dec 31, 2022Dec 31, 2022
United States
124.59M 124.59M 124.59M 121.24M 121.24M 121.24M 114.87M 114.87M 114.87M 133.14M 133.14M 133.14M 141.65M 141.65M 141.65M 134.91M 134.91M 134.91M 161.96M 161.96M 161.96M 146.14M 146.14M 146.14M
United States Growth
-12.05% -12.05% -12.05% -10.14% -10.14% -10.14% -29.08% -29.08% -29.08% -8.89% -8.89% -8.89% 0.83% 0.83% 0.83% -6.07% -6.07% -6.07% 31.08% 31.08% 31.08% - - -
EMEA
80.70M 80.70M 80.70M 81.54M 81.54M 81.54M 65.65M 65.65M 65.65M 33.86M 33.86M 33.86M 32.48M 32.48M 32.48M 29.50M 29.50M 29.50M 29.14M 29.14M 29.14M 27.69M 27.69M 27.69M
EMEA Growth
148.50% 148.50% 148.50% 176.37% 176.37% 176.37% 125.33% 125.33% 125.33% 22.28% 22.28% 22.28% 14.51% 14.51% 14.51% 3.03% 3.03% 3.03% -15.43% -15.43% -15.43% - - -
APAC
31.23M 31.23M 31.23M 26.38M 26.38M 26.38M 25.80M 25.80M 25.80M 25.18M 25.18M 25.18M 25.47M 25.47M 25.47M 23.00M 23.00M 23.00M 24.57M 24.57M 24.57M 31.14M 31.14M 31.14M
APAC Growth
22.62% 22.62% 22.62% 14.69% 14.69% 14.69% 5.02% 5.02% 5.02% -19.14% -19.14% -19.14% -16.40% -16.40% -16.40% -15.44% -15.44% -15.44% 13.33% 13.33% 13.33% - - -
Rest of World
1.40M 1.40M 1.40M 1.35M 1.35M 1.35M 1.22M 1.22M 1.22M 1.16M 1.16M 1.16M 1.03M 1.03M 1.03M 1.07M 1.07M 1.07M 1.00M 1.00M 1.00M -5.59M -5.59M -5.59M
Rest of World Growth
35.43% 35.43% 35.43% 25.94% 25.94% 25.94% 21.68% 21.68% 21.68% - - - - - - - - - -21.06% -21.06% -21.06% - - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.